Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
September 16, 2014, 07:40:10 AM

Login with username, password and session length


Members
Stats
  • Total Posts: 638905
  • Total Topics: 48503
  • Online Today: 190
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Bad Adherence Can Kill  (Read 1112 times)

0 Members and 1 Guest are viewing this topic.

nychope1

  • Guest
Bad Adherence Can Kill
« on: November 17, 2010, 01:23:56 PM »
I guess I felt compelled to post this after reading another members issues with remembering to take their meds as well as thinking of stopping them. I post this with only good intentions. I wish everyone here the strength and wisdom to make good decisions and do what is best for them.

The whole article can be found here: http://www.thebody.com/content/art12281.html#adherence

Bad Adherence Can Kill

Before people with HIV began taking potent antiretrovirals, the retrovirus killed nearly everyone it infected. In countries that cannot provide antiretrovirals for HIV-infected people, those people are dying today. So it should be no surprise that people who can get antiretrovirals -- but take them haphazardly or not at all -- will die as well.

Anyone who doubts that bad adherence kills might consult two studies in British Columbia, where antiretrovirals are free. The first involved 1,281 antiretroviral-naive adults beginning triple therapy between August 1996 and December 1999.9 Defining "intermittent therapy" as filling fewer than 75 percent of prescriptions in the first year of treatment, University of British Columbia researchers used a multivariate model to isolate only two factors that raised the risk of death: Each 100-cell decrement in pretreatment CD4 count raised the risk 1.31 times, and intermittent therapy raised the risk 2.90 times (P<0.001 for both). The researchers ran a subanalysis on people with at least one year of follow-up to eliminate a statistical bias called downward drift -- the chance that less frequent use of antiretrovirals in the first year simply marked more rapid HIV disease progression. This subanalysis confirmed the tie between poor adherence and death.

A more recent and larger study by the same group found that poor adherence outweighed baseline CD4 count in predicting mortality.39 Everyone in the 1,422-person cohort started potent antiretroviral therapy between August 1, 1996 and July 31, 2000. Follow-up continued until March 31, 2002. Again the Vancouver team figured adherence by prescription filling and limited statistical scrutiny to the first year of treatment.
« Last Edit: November 17, 2010, 02:52:59 PM by nychope1 »

 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.